Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mucin 5B antisense RNA 1 (MUC5B-AS1) is a long non-coding RNA (lncRNA) transcribed from the antisense strand of the MUC5B gene locus on chromosome 11p15.5[2]. As a cytoplasmic lncRNA approximately 434 nucleotides in length, MUC5B-AS1 forms an RNA–RNA duplex with MUC5B mRNA, thereby increasing its stability and leading to enhanced MUC5B expression[2][1][3]. MUC5B-AS1 has been shown to function as an oncogenic lncRNA in lung adenocarcinoma, where it promotes cancer cell migration, invasion, and metastasis by upregulating MUC5B. The mutual stabilization between MUC5B-AS1 and MUC5B may serve as a novel therapeutic avenue for chemotherapeutic intervention, although MUC5B-AS1 itself is not a current direct therapeutic target and no drugs are known to specifically interact with it[3][2]. Elevated MUC5B-AS1 and MUC5B expression have prognostic significance in lung adenocarcinoma but are not directly tied to other major disease categories[3][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mucin 5B antisense RNA 1 (MUC5B-AS1).